Chad Tang is a radiation oncologist at MD Anderson Cancer Center and associate professor in the department of genitourinary radiation oncology. He has joint appointments in the department of investigational cancer therapeutics and translational molecular pathology. He received his MD from Stanford University and completed residency at MD Anderson Cancer Center. His research and clinical practice focus on the treatment of advanced prostate and renal cell carcinomas with an emphasis on oligometastatic and oligoprogressive patients. He has completed and continues to run several investigator-initiated clinical trials investigating these disease states with an emphasis on translational correlatives.